Xlife Sciences AG (XLS) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
Xlife Sciences AG

BRIEF

published on 04/25/2025 at 07:05, 7 months 10 days ago

Xlife Sciences AG Reports Strategic Growth and Technological Milestones in 2024

Strategic Partnerships Dual Listing Technological Advancement Xlife Sciences AG Annual Report 2024
PRESS RELEASE

published on 04/25/2025 at 07:00, 7 months 10 days ago

Xlife Sciences AG publishes 2024 Annual Report: Strategic Expansion, Technological Milestones, and International Capital Market Presence
Xlife Sciences AG publishes 2024 Annual Report highlighting strategic partnerships, technological milestones, and dual listing plans on SIX and LSE to enhance international market presence

Strategic Partnerships Dual Listing Xlife Sciences AG 2024 Annual Report Technological Milestones
BRIEF

published on 04/23/2025 at 07:05, 7 months 12 days ago

VERAXA Biotech AG to Merge with Voyager Acquisition Corp.

Nasdaq Listing Cancer Therapeutics VERAXA Biotech AG Voyager Acquisition Corp. BiTAC Platform
PRESS RELEASE

published on 04/23/2025 at 07:00, 7 months 12 days ago

From Lab to Unicorn: Xlife Sciences AG Portfolio Company VERAXA Biotech AG to merge with Voyager Acquisition Corp. listed on NASDAQ
Xlife Sciences AG's portfolio company VERAXA Biotech AG to merge with Voyager Acquisition Corp., valuing VERAXA at USD 1.64 billion. Nasdaq listing planned for Q4 2025

Nasdaq Biopharmaceutical Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF

published on 12/23/2024 at 18:40, 11 months 12 days ago

Potential Acquisition of FUSE-AI GmbH by Pineapple Power Corporation

Acquisition Xlife Sciences FUSE-AI GmbH Pineapple Power Medical AI
PRESS RELEASE

published on 12/23/2024 at 18:35, 11 months 12 days ago

Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI GmbH by Pineapple Power Corporation PLC at an Expected Valuation of EUR 80-90 million
Xlife Sciences AG announces potential acquisition of FUSE-AI GmbH by Pineapple Power Corporation PLC at EUR 80-90 million valuation, marking a significant milestone in medical AI innovation

Acquisition Xlife Sciences AG FUSE-AI GmbH Medical AI Pineapple Power Corporation PLC
BRIEF

published on 12/19/2024 at 07:05, 11 months 17 days ago

Xlife Sciences AG Releases 2023 ESG Report Highlighting Sustainable Innovation

Healthcare Technology Environmental Impact Sustainable Innovation ESG Report Responsible Innovation
PRESS RELEASE

published on 12/19/2024 at 07:00, 11 months 17 days ago

Xlife Sciences AG Publishes 2023 ESG Report: A Continued Commitment to Sustainable Innovation
Xlife Sciences AG releases 2023 ESG Report, showcasing commitment to sustainable innovation. Report aligns with GRI Standards and emphasizes environmental, social, and governance performance

Innovation Sustainability Xlife Sciences AG GRI Standards ESG Report
BRIEF

published on 12/16/2024 at 07:05, 11 months 20 days ago

Xlife Sciences AG Announces VERAXA Biotech's Planned NASDAQ Listing

Nasdaq Listing Cancer Therapies VERAXA Biotech Biopharmaceutical Growth Xlife Sciences Strategy
PRESS RELEASE

published on 12/16/2024 at 07:00, 11 months 20 days ago

Xlife Sciences AG Announces the Intended Listing of VERAXA Biotech AG on the NASDAQ Stock Exchange in the 2025 Fiscal Year
Xlife Sciences AG announces the intended listing of VERAXA Biotech AG on the NASDAQ Stock Exchange in the 2025 fiscal year, aiming to advance novel cancer therapies and create value for shareholders

Shareholders Xlife Sciences AG Cancer Therapies VERAXA Biotech AG NASDAQ Stock Exchange

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 34 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 39 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 6 hours 9 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 4 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 9 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 39 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 18 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 44 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 54 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 58 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 13 hours 9 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 24 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 25 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE